Study Led by Roswell Park's Dr. Sai Yendamuri Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
September 08, 2025
September 08, 2025
BUFFALO, New York, Sept. 8 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Study Led by Roswell Park's Dr. Sai Yendamuri Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
*
BUFFALO, N.Y. -- Lung cancer patients who take medications called GLP-1 receptor agonists -- commonly prescribed for weight loss and diabetes management -- fare better than those who don't, a . . .
* * *
Study Led by Roswell Park's Dr. Sai Yendamuri Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
*
BUFFALO, N.Y. -- Lung cancer patients who take medications called GLP-1 receptor agonists -- commonly prescribed for weight loss and diabetes management -- fare better than those who don't, a . . .